Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
VJHemOnc is pleased to be a media partner for the 3rd European Research Initiative on CLL (ERIC) International Meeting, New Frontiers in CLL Research, which took place on 6-8 October 2022 in Barcelona, Spain, and gathered leading experts in CLL to discuss the most exciting updates in this field. Visit ericll2022.orgto find out more about ERIC.
Watch our excellent interview with Manali Kamdar (@mana1981) of @CUCancerCenter to hear the findings of subgroup analyses of the TRANSCEND-NHL-001 trial #MantleCellLymphoma cohort!
Tagraxofusp, a first‐in‐class #CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature - Jen - 2024 - Cancer | @jenweiying @mkonople @doctorpemm #endcancer #BPDCN @JournalCancer
Check out this week's podcast, where you'll learn about the role of BTK inhibitors in the treatment of mantle cell lymphoma, directly from leading experts! 🎧🩸
The European Research Initiative on CLL 2022 Meeting
06–08 October 2022 | Barcelona, Spain
VJHemOnc is pleased to be a media partner for the 3rd European Research Initiative on CLL (ERIC) International Meeting, New Frontiers in CLL Research, which took place on 6-8 October 2022 in Barcelona, Spain, and gathered leading experts in CLL to discuss the most exciting updates in this field. Visit ericll2022.orgto find out more about ERIC.
Watch our excellent interview with Manali Kamdar (@mana1981) of @CUCancerCenter to hear the findings of subgroup analyses of the TRANSCEND-NHL-001 trial #MantleCellLymphoma cohort!
Tagraxofusp, a first‐in‐class #CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature - Jen - 2024 - Cancer | @jenweiying @mkonople @doctorpemm #endcancer #BPDCN @JournalCancer
Check out this week's podcast, where you'll learn about the role of BTK inhibitors in the treatment of mantle cell lymphoma, directly from leading experts! 🎧🩸
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.